VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 27 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,010,017 | -35.5% | 1,369,623 | 0.0% | 2.53% | -45.0% |
| Q2 2023 | $32,583,331 | -6.5% | 1,369,623 | 0.0% | 4.59% | -23.3% |
| Q1 2023 | $34,843,209 | -12.9% | 1,369,623 | 0.0% | 5.99% | -5.6% |
| Q4 2022 | $40,006,688 | +42.4% | 1,369,623 | 0.0% | 6.35% | +28.5% |
| Q3 2022 | $28,091,000 | +157.2% | 1,369,623 | +45.1% | 4.94% | +97.5% |
| Q2 2022 | $10,923,000 | -37.4% | 944,092 | 0.0% | 2.50% | -39.4% |
| Q1 2022 | $17,456,000 | -6.5% | 944,092 | 0.0% | 4.13% | -32.9% |
| Q4 2021 | $18,665,000 | +20.2% | 944,092 | 0.0% | 6.15% | +9.0% |
| Q3 2021 | $15,530,000 | +2319.0% | 944,092 | +2590.3% | 5.65% | +2039.0% |
| Q2 2021 | $642,000 | +10.5% | 35,092 | 0.0% | 0.26% | +7.8% |
| Q1 2021 | $581,000 | – | 35,092 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $68,684,566 | 13.41% |
| COMMODORE CAPITAL LP | 2,189,659 | $55,704,925 | 8.48% |
| Fairmount Funds Management LLC | 1,369,623 | $34,843,209 | 5.99% |
| Paradigm Biocapital Advisors LP | 2,085,698 | $53,060,157 | 5.03% |
| Octagon Capital Advisors LP | 1,185,000 | $30,146,400 | 4.34% |
| Logos Global Management LP | 950,000 | $24,168,000 | 3.46% |
| TCG Crossover Management, LLC | 663,610 | $16,882,238 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 168,000 | $4,273,920 | 3.15% |
| Vivo Capital, LLC | 1,678,207 | $42,693,586 | 2.96% |
| TANG CAPITAL MANAGEMENT LLC | 692,925 | $17,628,012 | 2.63% |